February 2016

DNA fingerprinting, a key for the survival of cancer patients who do not respond to standard treatments

Leave a Comment / Uncategorised / By

Jaume Giró, General Manager of the “La Caixa” Bank Foundation, and Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Institute of Biomedical Research (IDIBELL), have presented today a pioneering study on epigenetic prediction of drug response to optimize cancer therapy in patients who no longer respond to standard treatments. The […]

DNA fingerprinting, a key for the survival of cancer patients who do not respond to standard treatments Read More »

ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities

Leave a Comment / Cancer, Neuroscience Program, Regenerative Medicine Program, Traslacional Medicine / By

The Direcció General de Recerca de la Secretaria d’Universitats i Recerca (Departament d’Empresa i Coneixement) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the optimization, adaptation, improvement of facilities and acquisition of technological equipment at  IDIBELL because of  the forthcoming integration of the Center for Regenerative Medicine in Barcelona (CMRB) in these spaces.

ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities Read More »

Scroll to Top